4th NovAliX Virtual Conference
After three virtual editions, we are extremely pleased to invite the biophysics and drug discovery community to a short virtual session.
The session will take place in November 17th.
The session will include two speakers on current topics in biophysics and drug discovery and will take place 8:00AM to 10:AM (PST) | 11:00AM to 1:00 PM (EST) | 17:00 to 19:00 Central European time (CET).
Registration is free of charge and open to any scientist interested in the use of biophysics in drug discovery.
The session will feature two interesting talks from:
- Dr Marc O’REILLY, VP of Molecular Sciences at Astex Pharmaceuticals, who will talk about the combined use of biophysics and structural biology in a target-centered approach, with a focus on covalent FBDD,
- Dr Iris ALROY, CSO of Anima Biotech Inc., who will tell us about new modalities (mRNA, tRNA, epitranscriptomics) and how to look at mRNA translation using a phenotypic approach involving AI to identify new targets.
The NovAliX Conferences are organized by LD Organisation.
Click on the “More information” button below to learn about the coming 4th virtual edition of the “NovAliX Conference”: Registration, speakers, topics, etc.